SEC Form 4 · accession 0001209191-15-070098
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nick Leschly
Officer — President and CEO · Director
Period of report
Sep 8, 2015
Accepted (ET)
Sep 10, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 8, 2015 | M | 125,000 | $5.5004 | A | 371,521 | D | |
| Common StockF2 | Sep 8, 2015 | S | 2,100 | $131.0064 | D | 369,421 | D | |
| Common StockF3 | Sep 8, 2015 | S | 8,300 | $131.7037 | D | 361,121 | D | |
| Common StockF4 | Sep 8, 2015 | S | 5,216 | $132.6365 | D | 355,905 | D | |
| Common StockF5 | Sep 8, 2015 | S | 12,241 | $133.9559 | D | 343,664 | D | |
| Common StockF6 | Sep 8, 2015 | S | 37,375 | $134.8592 | D | 306,289 | D | |
| Common StockF7 | Sep 8, 2015 | S | 22,610 | $135.752 | D | 283,679 | D | |
| Common StockF8 | Sep 8, 2015 | S | 25,758 | $136.8012 | D | 257,921 | D | |
| Common StockF9 | Sep 8, 2015 | S | 10,200 | $137.7611 | D | 247,721 | D | |
| Common Stock | Sep 8, 2015 | S | 1,200 | $138.53 | D | 246,521 | D | |
| Common Stock | holding | — | — | — | 7,504 | I | Nick Leschly 2001 Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F10 | $5.5004 | Sep 8, 2015 | M | 125,000 | D | — | Jan 16, 2023 | Common Stock | 125,000 | 265,269 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015.
- F10This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.
- F2The range of prices for the transaction reported on this line was $130.14 to $131.14. The average weighted price was $131.0064. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $131.16 to $132.12. The average weighted price was $131.7037. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $132.31 to $133.29. The average weighted price was $132.6365. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range of prices for the transaction reported on this line was $133.32 to $134.32. The average weighted price was $133.9559. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range of prices for the transaction reported on this line was $134.33 to $135.33. The average weighted price was $134.8592. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7The range of prices for the transaction reported on this line was $135.34 to $136.30. The average weighted price was $135.7520. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8The range of prices for the transaction reported on this line was $136.35 to $137.34. The average weighted price was $136.8012. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F9The range of prices for the transaction reported on this line was $137.375 to $138.185. The average weighted price was $137.7611. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.